Posted by Capsule Course on “Medical Law, Patient Safety and Ethics: Contemporary Issues” @ Symbiosis Law School, Pune
Symbiosis Law School, Pune is proud to announce that we shall be conducting a Capsule Course on “Medical Law, Patient Safety and Ethics: Contemporary Issues” in collaboration with Symbiosis Institute of Health Sciences (SIHS) and Core India Institute of Legal Medicine (CILM) from 8th May to 12th May 2017.
Resource persons will include experts from Nottingham Trent University UK, AUT School of Law, New Zealand, AIIMS Delhi, academicians, administrators as well as renowned medical professionals from all over India.
Registration for this Capsule course is now open to both students, professionals of Law or Medicine. Please note that the admission will be done on a ‘First Come First Serve Basis’; subject to maximum limit of 100.
The Capsule Course aims at understanding the relationship between law and medicine. The course gives an insight into medical law and ethics, and deliberates over the issues of the rights of patients in relation to health, safety and information. The course would additionally bring to light the contemporary issues and challenges to healthcare.
On the successful completion of the course, a certificate will be awarded for the participants at the end of the programme.
Fee:
The admission fee for students is Rs.2,500 /- and for professionals Rs. 5, 000 /- only. Interested participants may register for the Capsule Course by writing to capsulecourse2017@symlaw.ac.in with their details and contact number. The Registration Form is attached with this email (DOC)
Online payment option is available. For queries, please contact capsulecourse2017@symlaw.ac.in
For further information, students/professionals may contact :
Dr. Aparajita Mohanty – amohanty@symlaw.ac.in
Prof. Asawari Abhyankar – agabhyankar@symlaw.ac.in
Prof. Shirish Kulkarni – sdkulkarni@symlaw.ac.in
Prof. Neethu Alex – alphonsa.alex@symlaw.ac.in
Prof. Sanjeet Ruhal – sanjeet.ruhal@symlaw.ac.in
LINK:
For Registration Form, CLICK HERE
871
265 comments
Comments are closed.